日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat

评估脱氧胆酸注射液在减少侧腰脂肪方面的疗效和安全性

期刊:Journal of Cosmetic Dermatology
影响因子:2.5
doi:10.1111/jocd.70436
Namakizadeh Esfahani, Navid; Khorasanizadeh, Faezeh; Ehsani, Amirhoushang; Nasimi, Maryam; Mahmoudi, Hamidreza; Kafi, Hamidreza; Sabzvari, Araz; Gholami, Hoshyar; Saeedi, Keysan; Balighi, Kamran
发表日期：2025
文献求助 收藏

A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta(®) (reference product) in previously treated patients with severe haemophilia A

一项随机、双臂、双盲、单剂量、交叉、生物等效性临床试验，旨在比较AryoGen Pharmed公司生产的重组人凝血因子VIII（含Fc融合蛋白）与Elocta®（参比制剂）在既往接受过治疗的重型A型血友病患者中的药代动力学参数和安全性。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06242-z
Eghbali, Aziz; Eshghi, Peyman; Toogeh, Gholamreza; Alavi, Samin; Badiei, Zahra; Ghanavat, Majid; Bordbar, Mohammadreza; Bazrafshan, Asghar; Karimi, Katayoon; Ahmadinejad, Minoo; Sabzvari, Araz; Kafi, Hamidreza
发表日期：2025
文献求助 收藏

Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac ®) versus branded tacrolimus (Prograf ®) in de novo liver transplant patients: a randomized clinical trial

评估通用名他克莫司（Suprotac®）与品牌他克莫司（Prograf®）在初次肝移植患者中的临床和安全性结果：一项随机临床试验

期刊:Daru-Journal of Pharmaceutical Sciences
影响因子:2.1
doi:10.1007/s40199-025-00574-x
Shafiekhani, Mojtaba; Jafarzadeh, Mohammad Amin; Ahmadi, Mohammad; Nikoupour, Hamed; Shamsaeefar, Alireza; Jafari, Keynoosh; Sohrabi Nazari, Sahar; Kafilzadeh, Kianaz; Gholami, Siavash; Zarei, Edalat; Kazemi, Kourosh; Sabzvari, Araz; Hosseini, Seyed Ali Malek; Nikeghbalian, Saman
发表日期：2025
文献求助 收藏

Evaluation of efficacy and safety of generic tacrolimus (Suprotac(®)) compared to reference tacrolimus (Prograf(®)) in kidney transplantation: a phase IV study

评估仿制他克莫司（Suprotac®）与参考他克莫司（Prograf®）在肾移植中的疗效和安全性：一项IV期研究

期刊:European Journal of Translational Myology
影响因子:1.8
doi:10.4081/ejtm.2025.13203
Einollahi, Behzad; Nafar, Mohsen; Javanbakht, Mohammad; Alirezaei, Amirhesam; Azmandian, Jalal; Etminan, Abbas; Ardalan, Mohammad Reza; Etemadi, Jalal; Akbari, Roghayeh; Pourfarziani, Vahid; Hashemi, Seyed Sadraddin Rasi; Rahbar, Seyed Maryam; Shahidi, Shahrzad; Safa, Javid; Khosroshahi, Hamid Tayyebi; Azar, Sima Abedi; Ossareh, Shahrzad; Atapour, Abdolamir; Marghoob, Bahareh; Nazemian, Fatemeh; Kafi, Hamidreza; Sabzvari, Araz
发表日期：2025
文献求助 收藏

A Comprehensive Review of the Role of the Latest Minimally Invasive Neurosurgery Techniques and Outcomes for Brain and Spinal Surgeries

最新微创神经外科技术在脑和脊柱手术中的作用及疗效的综合评价

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.84682
Laguardia, Simone; Piccioni, Alessio; Alonso Vera, Jorge Eduardo; Muqaddas, Ali; Garcés, Milko; Ambreen, Sidra; Sharma, Sarmishtha; Sabzvari, Tara
神经科学
发表日期：2025
文献求助 收藏

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

一项多中心、III期、随机、双盲、等效性临床试验，旨在比较拟上市的奥马珠单抗生物类似药与原研药在治疗未控制的中重度过敏性哮喘方面的疗效和安全性。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1425906
Ghanei, Mostafa; Ghalebaghi, Babak; Sami, Ramin; Torabizadeh, Mehdi; Mirsadraee, Majid; Amra, Babak; Tavakol, Marzieh; Raji, Hanieh; Fallahpour, Morteza; Kiani, Arda; Abedini, Atefeh; Jabbari Azad, Farahzad; Mahdaviani, Seyed Alireza; Attaran, Davood; Samet, Mohammad; Tavana, Sasan; Haddadzadeh Shoushtari, Maryam; Nazari, Javad; AghaeiMeybodi, FatemehAlsadat; Fazlollahi, Mohammad Reza; Ghasemi, Ramin; Sabzvari, Araz; Kafi, Hamidreza; Idani, Esmaeil
哮喘
发表日期：2024
文献求助 收藏

Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial

评估奥克瑞珠单抗生物类似药（Xacrel）与原研药（Ocrevus）在复发型多发性硬化症中的疗效和安全性：一项III期随机等效性临床试验

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-75745-y
Sahraian, Mohammad Ali; Abolfazli, Roya; Shaygannejad, Vahid; Ashtari, Fereshteh; Majdinasab, Nastaran; Navardi, Samira; Baghbanian, Seyed Mohammad; Sedighi, Behnaz; Naser Moghadasi, Abdorreza; Nahayati, Mohammad Ali; Ghalyanchi Langroodi, Hamidreza; Mohammadianinejad, Seyed Ehsan; Beladi Moghadam, Nahid; Ayromlou, Hormoz; Nikseresht, Alireza; Ghiasian, Masoud; Razazian, Nazanin; Asadollahzadeh, Elnaz; Sabzvari, Araz; Kafi, Hamidreza; Albooyeh, Sogol
神经科学
多发性硬化症
发表日期：2024
文献求助 收藏

A Comprehensive Review of Recent Trends in Surgical Approaches for Epilepsy Management

癫痫外科治疗最新进展的综合综述

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.71715
Sabzvari, Tara; Aflahe Iqbal, Muhammed; Ranganatha, Akash; Daher, Jean C; Freire, Isabel; Shamsi, Syeda Maham Fatima; Paul Anthony, Oriona Vinishia; Hingorani, Anusha G; Sinha, Aparita S; Nazir, Zahra
癫痫
神经科学
发表日期：2024
文献求助 收藏

Advancements in Imaging and Neurosurgical Techniques for Brain Tumor Resection: A Comprehensive Review

脑肿瘤切除术影像学和神经外科技术的进展：一项综合综述

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.72745
Vadhavekar, Nidhi H; Sabzvari, Tara; Laguardia, Simone; Sheik, Thuslim; Prakash, Varsha; Gupta, Aseem; Umesh, Indra Dhanush; Singla, Abhinandan; Koradia, Ikhlaq; Ramirez Patiño, Brando B; Siddiqui, Humza F
肿瘤
肿瘤免疫
神经科学
发表日期：2024
文献求助 收藏

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

评估 SpikoGen®（一种含 Advax-CpG55.2 佐剂的严重急性呼吸综合征冠状病毒 2 刺突蛋白疫苗）的有效性和安全性：一项 3 期随机安慰剂对照试验

期刊:Clinical Microbiology and Infection
影响因子:8.5
doi:10.1016/j.cmi.2022.09.001
Tabarsi, Payam; Anjidani, Nassim; Shahpari, Ramin; Mardani, Masoud; Sabzvari, Araz; Yazdani, Babak; Kafi, Hamidreza; Fallah, Newsha; Ebrahimi, Ali; Taheri, Ali; Petrovsky, Nikolai; Barati, Saghar
微生物学
发表日期：2023
文献求助 收藏